Yun Deng - Publications

Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: May 20, 2024

Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases.

Journal: Translational cancer research

Published: July 27, 2023

Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer.

Journal: Frontiers in oncology

Published: February 15, 2022

SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells.

Journal: Cell death & disease

Published: October 23, 2021

DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection.

Journal: Aging

Published: October 01, 2019

A review of automatic liver tumor segmentation based on computed tomography

Journal: Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi

Published: June 26, 2018

Improved survival in ovarian cancer, with widening survival gaps of races and socioeconomic status: a period analysis, 1983-2012.

Journal: Journal of Cancer

Published: March 26, 2018

Erratum to: Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 23, 2016

Staged Improvement in Awareness of Disease for Elderly Cancer Patients in Southern China.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: October 06, 2015

Deceptive information and the financial burden for Chinese cancer patients.

Journal: The Lancet. Oncology

Published: July 04, 2014

Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: June 12, 2014